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Background: Subunit 55 of TFIIIC contains a phosphatase domain of unknown function.
Results: Crystal structures of the 55 phosphatase domain and its paralogue Huf, in silico docking, in vitro candidate
approaches, and in vivo phosphoproteomics identified phosphopeptides as substrates.
Conclusion: 55-HPD and Huf hydrolyze phosphopeptides in proteins of different cellular functions.
Significance: Protein phosphatase activities of 55 and Huf contribute to regulating metabolic networks.
Saccharomyces cerevisiae 55, a subunit of the RNA polymer-
ase III-specific general transcription factor TFIIIC, comprises
an N-terminal histidine phosphatase domain (55-HPD) whose
catalytic activity and cellular function is poorly understood.We
solved the crystal structures of 55-HPD and its closely related
paralogue Huf and used in silico docking methods to identify
phosphoserine- and phosphotyrosine-containing peptides as
possible substrates that were subsequently validated using in
vitro phosphatase assays. A comparative phosphoproteomic
study identified additional phosphopeptides as possible targets
that show the involvement of these two phosphatases in the reg-
ulation of a variety of cellular functions. Our results identify
55-HPD andHuf as bona fide protein phosphatases, character-
ize their substrate specificities, and provide a small set of regu-
lated phosphosite targets in vivo.
RNA polymerase III (Pol III)2 is the most complex of the
three eukaryotic RNA polymerases and is responsible for the
synthesis of various small, noncoding RNAs including tRNAs
(1). Pol III-dependent transcription of tRNA genes controlled
by type 2 promoters requires the transcription factor IIIC
(TFIIIC) to bind to two gene-internal elements named the
A-box and B-box (2), thereby inducing the recruitment of the
transcription factor IIIB (TFIIIB) and subsequently the recruit-
ment of Pol III (3). Saccharomyces cerevisiae TFIIIC is a six-
subunit complex of 0.5 MDa consisting of the two subcom-
plexes A (harboring the 131, 95, and 55 subunits) and B
(harboring the 138, 91, and 60 subunits) that bind to the A-
and B-boxes, respectively (4). The S. cerevisiae 55 protein con-
sists of an N-terminal domain predicted to belong to the histi-
dine phosphatase family and aC-terminal domain necessary for
its interaction with 95. The N-terminal histidine phosphatase
domain of the 55 protein (55-HPD) is only found in hemias-
comycetes, whereas corresponding subunits in other eukary-
otes only contain the C-terminal moiety required for the inter-
action with 95 orthologues (5). Because of a gene duplication
event, S. cerevisiae has also evolved a paralogue of the 55-HPD
as an independent protein, called Huf.
Both proteins, 55-HPD and Huf, belong to the first branch
of the histidine phosphatase family that has been originally
termed the phosphoglycerate mutase family, according to its
foundingmember, the eponymous enzyme, which catalyzes the
conversion of 2-phosphoglycerate to 3-phosphoglycerate (6, 7).
The first branch of the histidine phosphatase family contains
enzymes with a broad range of enzymatic activities, including
the phosphoglyceratemutase and the fructose-2,6-bisphospha-
tase enzymes, as well as the protein phosphatases Sts-1 (supres-
sor of T-cell signaling-1) and Sts-2, which also represent the
closest homologues of 55-HPD in higher eukaryotes (8). In the
second branch, the enzymatic activities are less diverse, includ-
ing mainly representatives of the acid phosphatase and phytase
categories. The two families have been linked through their
characteristic short RHG peptide motif at the N-terminal end
of their amino acid sequences (9).
The presence of an enzyme fused to a transcriptional regula-
tor subunit has been unexpected. Because no enzymatic activity
had been detected for 55 and because 55-HPD is nonessential
and not required for TFIIIC activity, only an auxiliary structural
role of 55-HPD in stabilizing TFIIIC had been suggested (10).
However, partial deletions of 55-HPD result in a reduced
growth rate at 30 °C or in thermo-sensitive phenotypes in glyc-
erol- or ethanol-containing media, suggesting a possible role
for 55-HPD in directly linking Pol III transcription with met-
abolic pathways. In addition, S. cerevisiae 55 and 95 form a
complex separate from TFIIIC and not required for TFIIIC
activity that has been also suggested to exert additional meta-
bolic functions (10). Finally, the functional role of the 55-HPD
paralogue Huf and possible redundancies with 55-HPD have
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also not been explored. There is increasing awareness about the
cross-talk between the metabolic state of the cell and Pol I and
Pol III transcription allowing cells to adapt to changing envi-
ronmental conditions. We therefore set out to further explore
the functional roles of 55-HPD and its paralogue Huf by char-
acterizing their potential phosphatase activities and substrate
preferences in vitro and by identifying potential in vivo phos-
pho-target sites by performing comparative phosphoproteomic
analyses. In a first step, we solved the crystal structures of
S. cerevisiae 55-HPD at 1.5 Å and Huf at 2.0 Å resolution,
respectively. Both structures show a canonical HPD fold, har-
boring the conserved catalytic active site residues. Consistently,
we could observe phosphatase activity for both of the purified
enzymes, which could be abolished by mutating conserved
active site residues. Based on the 55-HPD crystal structure, we
subsequently performed in silico docking studies of phosphate-
containing small molecules and phospho-di- and tripeptides to
identify potential substrates. Several known transcription-re-
lated phosphopeptides were tested in in vitro dephosphory-
lation assays using purified 55-HPD and Huf proteins. In an
independent unbiased approach, we also compared the phos-
phoproteomes of wild type and double knock-out (55-HPD
huf) yeast strains to identify phosphosites that are under the
direct and indirect regulation of these two potentially redun-
dant phosphatases in vivo.
EXPERIMENTAL PROCEDURES
Yeast Strain Preparation—SCCM3 (ade2–101, his3-200,
lys2–801, trp1-63, ura3–52, tfc7::HIS3 pHA-Tfc7 (cen;
TRP1)) and SCCM8 (ade2–101, his3-200, lys2–801, trp1-
63, ura3–52, huf::KanMX4, tfc7::HIS3 pHA-Tfc7N (cen;
TRP1)) were the yeast strains analyzed for differences in their
phosphoproteome. To obtain SCCM3, the TFC7 plasmid in
YNM2 (ade2–101, his3-D200, lys2–801, trp1-D63, ura3–52,
tfc7D::HIS3 pTFC7 (2; URA3)) was substituted for pHA-Tfc7
(TRP1) by plasmid shuffling on plates with 5-fluoro-orotic acid.
For construction of SCCM8, a DNA fragment bearing the
KanMX4 marker flanked by HUF upstream and downstream
sequences was cut out from pYCG-YNL108c (EUROSCARF)
and transformed into YNM2. KanMX4-positive cells were
selected on plates with G418, and deletion of the HUF open
reading framewas confirmed by colony PCR. Subsequently, the
pNM2 plasmid was substituted for pHA-Tfc7N (TRP1) by
plasmid shuffling on plates with 5-fluoro-orotic acid.
Protein Preparation—Full-length untagged 55 protein was
expressed inHigh-Five insect cells using the baculovirus system
(virus kindly provided by J. Acker) and purified by anion
exchange chromatography (Q Sepharose FF 16/10 column; GE
Healthcare) and gel filtration chromatography (HiLoad 26-
600 Superdex 200; GE Healthcare) to homogeneity. 55 was
treated overnight at 4 °C with trypsin, added in a mass-to-mass
ratio of 1:1000. After the limited proteolysis step, the resulting
proteolytic fragment was separated, purified, and concentrated
to 18.5 g/liter. For biochemical assays, 55-HPD (residues
1–270) was cloned into the pETM10 vector, giving rise to a
noncleavable, N-terminal His tag on the resulting protein. The
protein was expressed in SoluBL21 Escherichia coli cells (co-
transformed with a pRare plasmid), purified by nickel-nitrilo-
triacetic acid affinity chromatography followed by anion
exchange using aQSepharoseHiTrap column and gel filtration
on a HiLoad 26/600 Superdex S200 column, and concentrated.
The gene encoding Huf was also cloned into the pETM10 vec-
tor. Expressionwas performedovernight at 18 °C inE. coliBL21
Star pRare cells. The proteinwas purified similarly to 55-HPD,
but bypassing the anion exchange step. The active site mutants
of 55-HPD and Huf were prepared using site-directed
mutagenesis and purified as described for the wild type HPD
proteins.
Protein Crystallization—Crystals of 55-HPD were obtained
using the hanging drop vapor diffusion method at a protein
concentration of 18.5 g/liter using a reservoir solution of 0.77 M
NaH2PO4 and 1.23 M K2HPO4. Crystals were cryoprotected
with 30% glycerol and flash frozen in liquid nitrogen. Crystals of
Huf were grown at 4 °C by hanging drop vapor diffusion, at a
protein concentration of 6.2 g/liter with a reservoir solution
consisting of 0.2 M magnesium formate and 26% PEG 3350.
Cryoprotection of the crystals was performed by a soak in
mother liquor supplemented with 8% glycerol, after which they
were flash frozen in liquid nitrogen.
X-ray Structure Determination—Data for native 55-HPD
andmercury-derivative crystals (soaked in 1mM ethyl-mercury
chloride) were collected at ESRF Beamline BM14. The 55-
HPD structure was solved by the single isomorphous replace-
ment with anomalous scattering method using data from the
mercury-soaked crystal and refined against the best native data
set to 1.50Å resolution. Data for theHuf crystals were collected
at ESRF Beamline ID29, and the structure was solved bymolec-
ular replacement using the 55-HPD structure as a search
model and refined to 2.05 Å resolution.
Docking—To investigate potential substrates in an unbiased
fashion (i.e., without limiting the docked molecules to phos-
phorylated compounds), 15,402 molecules of the Kyoto Ency-
clopedia of Genes and Genomes database (11, 12) of natural
compounds were used. For a more focused docking of possible
peptide substrates, an in-house generated library of phosphor-
ylated dipeptides and selected tripeptides was used that corre-
sponded to the central portions of the peptides that were also
tested in vitro. Docking calculations were performed with
DOCK3.5 (13–16). During docking, every molecule was fitted
onto predetermined anchor points in the binding site. Each
molecule pose was minimized for 25 steps with the simplex
method.
Phosphatase Activity Assays—Phosphatase activity assays
were performed using 3-O-methyl-fluorescein (Sigma) as sub-
strate. Kinetic parameters (Km, Vmax, and kcat) were analyzed
with Origin 7.0 using nonlinear regression analysis and
Michaelis-Menten equation. For peptide dephosphorylation
assays, free phosphate levels were detected using PiColorLock
Gold Assay kit (Innova Biosciences) according to the manufac-
turer’s instructions.
Comparative Phosphoproteomic Analysis—Strains were grown
in YPDA medium until optical density of 1.0 at 30 °C. The
cells were harvested and lysed in buffer A (50mM sodium phos-
phate, pH 7.4, 100 mM NaCl, 1 mM DTT, 1 mM NaF, 0.5 mM
orthovanadate, phosphatase (PhosSTOP), and protease inhibi-
tors) using glass beads. Lysate was cleared by centrifugation.
Structure-Function Analysis of 55-HPD and Huf
MAY 24, 2013•VOLUME 288•NUMBER 21 JOURNAL OF BIOLOGICAL CHEMISTRY 15111
 at CSIC - Centro de Investigaciones Biológicas on Septem
ber 13, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
The samples were either directly used for protein digestion or
used for heparin affinity chromatography, where 100 mg of
cleared lysate was bound to a HiTrap Heparin HP column (GE
Healthcare) washed with 50 ml of buffer A and eluted using
buffer B (buffer A containing 1200 mM NaCl). Eluate was col-
lected and used for protein digestion. Proteins were reduced
and carbamidomethylated with dithiothreitol and iodoacet-
amide, respectively. Subsequently, proteins were digested with
lysyl endopeptidase (Wako) for 4 h at 37 °C followed by a tryptic
(Promega) digestion overnight at 37 °C. Peptides were desalted
and differentially dimethyl-labeled (light and intermediate) on
Sep-Pak tC18 1-cc 100-mg cartridges (Waters) as described
(17). Replicate samples were labeled with the inverse labels
(label swap), meaning theWTwas labeled light in one replicate
and intermediate in the other replicate and vice versa for 55-
HPD huf. The labeled WT sample was mixed with the cor-
responding labeled 55-HPD huf sample, and an aliquot was
analyzed by LC-MS/MS. The rest of the mixture was concen-
trated and enriched for phosphopeptides. TiO2 phosphopep-
tide enrichment by Ti (IV) immobilized metal affinity chroma-
tography was carried out as described (18). The eluate was
acidified with 10% formic acid and was either directly analyzed
or further concentrated and diluted with 1% formic acid prior
to LC-LC-MS/MS analysis. Peptides were analyzed on a nano-
Acquity UPLC system (Waters) directly connected to an LTQ
Orbitrap Velos Pro (Thermo Scientific) via a Proxeon nanos-
pray source. The utilized columnswere a nanoAcquity Symme-
try C18, 5m, 180m 20mm (Waters) trapping column and
a nanoAcquity BEH C18, 1.7 m, 75 m  200 mm (Waters)
analytical column. Themobile phasesA andB consisted of 0.1%
formic acid in water and acetonitrile, respectively. The applied
three-step gradients varied in length between 120 and 360min,
ranging from 3 to 85%mobile phase B at a constant flow rate of
300 nl/min. The eluent was directly introduced into the mass
spectrometer via a Pico-Tip Emitter 360-m outer diameter
20-m inner diameter; 10-m tip (New Objective) with 2.2 kV
applied spray voltage and capillary temperature of 300 °C. MS
analysiswas performed in positive ionmode. Full scanMS spec-
tra were recorded from 300 to 2000m/z in profile mode in the
Orbitrap. Resolution in MS mode was set to 30,000. Lock mass
correction using a background ion at m/z 445.12003 was used
for internal calibration. The 10 most intense parent ions were
subjected to fragmentation by higher energy collisional disso-
ciation with the normalized collision energy set to 40%. Charge
state screening was enabled to prevent fragmentation of singly
charged ions. The resolution for MS/MS was set to 7500.
Heparin-enriched samples were digested, dimethyl-labeled,
mixed, and subjected to strong cation exchange chromatogra-
phy. Strong cation exchange chromatography was performed
on an UltiMate 3000 HPLC (Dionex) coupled to a CapLC 2487
UV detector (Waters) using a 50 1-mm polysulfoethyl A col-
umnwith 3-mparticles, pore size of 300 Å, at a flow rate of 75
l/min. Buffer A consisted of 1mMKH2PO4, 0.05% formic acid,
and 30% acetonitrile, buffer B of 350 mM KCl, 5 mM KH2PO4,
0.05% formic acid, and 30% acetonitrile. Only one early fraction
enriched in neutral or acidic phosphopeptides as described in
Ref. 19 was concentrated, desalted, and subjected to either
direct LC-MS/MS analysis or following TiO2 enrichment.
Rawdatawere processedwith ProteomeDiscoverer software
version 1.3.0.339 (Thermo Scientific). The data were filtered
with a Top N peaks filter set to 10 with a 100-Da mass window
prior to database searching. The filtered data were searched
against the UniProt yeast database (6878 sequences). Mascot
version 2.2 (Matrix Science) was used as search algorithm with
the following parameters: trypsin allowing two missed cleav-
ages; precursor mass tolerance, 20 ppm, fragment mass toler-
ance, 0.02 Da; carbamidomethylation as static modification for
cysteine; oxidation on methionine, phosphorylation on serine,
threonine, and tyrosine, light and intermediate dimethylation
on lysine and the N terminus as dynamic modifications. Algo-
rithm phosphoRS was used to score phosphorylation sites of
the phosphopeptides and quantification node implemented in
Proteome Discoverer for quantification. Mass precision herein
was set to 2 ppm, and retention time tolerance of isotope pat-
ternmultiplets was set to 0.5min. The percolator implemented
in Proteome Discoverer was used to calculate the false discov-
ery rate of 1%. Only peptides with high confidence (q value of
Percolator below or equal to 0.01) were taken for peptide and
protein reporting. For protein grouping only peptide spectrum
matcheswith high confidence and aCn better than 0.15where
selected, and strictmaximumparsimony principlewas enabled.
The proteins were only considered to be regulated when they
had a score greater than or equal to 20, were identified with at
least three unique peptides, and were at least 2-fold up- or
down-regulated in both replicates. Phosphopeptides were con-
sidered to be regulated only when they were identified in both
replicates with a q value below 0.01 and were at least 2-fold up-
or down-regulated in both replicates.
RESULTS
Structure Determination of 55-HPD and Its Paralogue
Huf—Full-length 55 protein was overexpressed in insect cells
and could be purified to homogeneity. Limited proteolysis
TABLE 1
Crystallographic statistics for 55-HPD
55-HPD
Native Mercury-derivative
Data collection
Space group P21212 P21212
Cell dimensions
a, b, c (Å) 80.6, 86.7, 44.3 80.5, 86.6, 44.4
Wavelength (Å) 1.00849 1.00514
Resolution (Å) 50.0-1.50 (1.54-1.50) 50.0-1.95 (2.00-1.95)
Rsym (%) 16.1 (98.7) 17.4 (81.3)
I/(I) 15.5 (2.19) 14.05 (2.27)
Completeness (%) 99.5 (99.9) 99.9 (99.6)
Multiplicity 4.05 (4.02) 4.24 (3.44)
Refinement
Resolution (Å) 43.4-1.50
No. reflections 50,251
Rwork/Rfree (%) 15.6/18.3
No. atoms
Protein 2,083
Other 5
Water 293
B-factor (Å2)
Protein 18.7
Other 32.1
Water 12.9
RMSD
Bond lengths (Å) 0.01
Bond angles (°) 1.248
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FIGURE 1. Structures of 55-HPD and Huf. A, structure of the 55-HPD proteins, with helices shown in green and -strands shown in yellow. The helices are
numbered, and the N and C termini are marked. The topology diagram of 55-HPD is shown as an inset. B, structure of the Huf protein, with helices shown in
brown and-strands shown in yellow. The topology diagramof Huf is shown in the inset. C, Structural alignment of 55-HPD, Huf, and the HPDs ofmouse Sts-1
(Protein Data Bank code 2IKQ), human F26BPase (Protein Data Bank code 1K6M), human BPGM (Protein Data Bank code 2H4Z), yeast dPGM (Protein Data Bank
code 5PGM), Bacillus stearothermophilus PhoE (Protein Data Bank code 1H2F), and E. coli SixA (Protein Data Bank code 1UJB). Secondary structure elements for
55-HPD andHuf aremarked above the structure. As inA and B, all sheets are colored yellow, and helices are colored green for 55-HPD, brown for Huf, and gray
for all other proteins. Conservedhelices that are absent in 55-HPDandHuf are shownasdotted lines. Conserved active site residues are shaded in red. Residues
corresponding to 55-HPD and Huf R14 are shaded in light blue. Sequences were aligned using structural information with STRAP (42).
Structure-Function Analysis of 55-HPD and Huf
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resulted in a stable domain corresponding to the predicted his-
tidine phosphatase domain of 55 (residues 1–272). After
obtaining crystals of 55-HPD, prepared by preparative limited
proteolysis, its structure could be solved using single isomor-
phous replacement with anomalous scattering and refined at a
resolution of 1.5 Å to Rwork/Rfree values of 15.6/18.3% (Table 1).
The structure shows a canonical histidine phosphatase fold of
the branch 1 subfamily. It consists of six -strands, forming a
mixed parallel/antiparallel -sheet that makes up the core of
the domain, surrounded by nine -helices (Fig. 1A).
Huf could also be crystallized, and its structure was solved by
molecular replacement, using the 55-HPD structure as search
model. The structure was subsequently refined at a resolution
of 2.05 Å to Rwork/Rfree values of 20.0/23.6% (Table 2). Huf and
55-HPD possess 64% sequence identity and show almost iden-
tical overall structures that can be superimposed with a RMSD
of 0.65Åover 237 residues. Differences are limited to theC-ter-
minal region, where helix 9 is absent in Huf, while present in
55-HPD. In contrast, Huf possesses an additional -helix
located more toward the C terminus, in a region that is disor-
dered in the 55-HPD structure (Fig. 1B). This latter helix in
Huf has been termed 10 to discriminate it from helix 9 in
55-HPD (Fig. 1B). In summary, the spatial organization of Huf
is very similar to that of the 55-HPD and other branch 1 histi-
dine phosphatases.
Structural Analysis andComparison of theActive Sites of 55-
HPD and Huf—The catalytic residues in the active sites (Arg-
10, His-11, Arg-68, His-169 (55)/His-168 (Huf)) are highly
conserved between 55-HPD, Huf, and all other known histi-
dine phosphatases (Fig. 1C). The putative proton donor (Glu-
92) is conserved among branch 1 histidine phosphatases. The
catalytic cavities of 55-HPD and Huf are positively charged,
and the spatial orientation of the catalytic residues is almost
identical in both enzymes (Fig. 2, A and B). Interestingly, we
could identify two different substrate/product mimics in the
putative catalytic sites of 55-HPD and Huf. We could locate a
phosphate ion from the crystallization buffer in the 55-HPD
active site, whereas a formate molecule is present in the active
site of Huf that was crystallized in formate containing buffer
(Fig. 2, A and B). In addition to side chain-specific contacts,
55-HPD Ala-170 makes a contact with the bound phosphate
through its main chain NH group, and the corresponding Huf
Ala-169makes an equivalent contact with the formate molecule.
Structural comparison reveals the highest structural similar-
ity of 55-HPDandHufwith Sts-1 and Sts-2 proteins (55-HPD
RMSDSts-1 2.10Åover 197 residues andRMSDSts-2 1.86
Å over 188 residues; Huf RMSD Sts-1  2.03 Å over 187 resi-
dues and RMSD Sts-2 1.93 Å over 186 residues), which both
show phosphotyrosine phosphatase activity (20, 21). Interest-
ingly, residue Arg-14 of 55-HPD and Huf, which contacts the
respective phosphate and formate ions in the active sites, is
conserved in Sts-1 and Sts-2 but not in other members of the
branch 1 histidine phosphatase family (Fig. 1C). In addition,
55-HPD, Huf, Sts-1, and Sts-2 lack two -helices, which are
located between4 and5 in the other branch 1histidine phos-
phatases. These four enzymes also share a specific subset of
nonconserved residues that were shown to regulate the specific
activity in Sts-1 and Sts-2 (22). These pieces of evidence indi-
cate that 55-HPD, Huf, Sts-1, and Sts-2 might act on similar
substrates andmight well represent a specific subbranchwithin
the branch 1 histidine phosphatase family.
55-HPD Is a Functional Phosphatase—As the catalytic res-
idues of 55-HPD and Huf are highly conserved and harbor all
necessary active site residues, we wondered whether these pro-
teins have catalytic activities, which were missed in previous
studies (10). We tested purified 55, 55-HPD, and Huf pro-
teins (Fig. 2C) for their ability to dephosphorylate 3-O-methyl
fluorescein phosphate, an unspecific substrate of phosphatases
(23, 24). All three tested proteins show phosphatase activity.
Importantly, 55 and 55-HPD show similar enzymatic activi-
ties and kinetic parameters (Fig. 2E), indicating that the C ter-
minus of 55 does not influence the phosphatase activity of
55-HPD and that the two domains act independently of each
other. Huf shows higher phosphatase activity, although sub-
strate binding constants are similar for both enzymes.
To test the specificity and conserved enzymatic reaction
mechanism, we generated mutated versions of 55-HPD and
Huf lacking signature catalytic residues known to be essential
for the phosphatase activity in other family members (8).
Although the stability of the mutated proteins is almost identi-
cal to the wild type proteins or even higher for R68A mutants
(Fig. 2D), we could observe a drastic drop of activity for all
mutated versions of the proteins (Fig. 2E).Mostmembers of the
large histidine phosphatase superfamily have been shown to be
active and have been assigned distinct enzymatic activities,
whereas this was not the case for 55-HPD andHuf. Our results
address this gap, and we now show that both proteins possess
phosphatase activity in vitro. In addition, we observed that the
enzyme kinetics of 55-HPD, Huf, and Sts-1 for OMFP are in a
comparable range (Fig. 2F), which again reflects the strong sim-
ilarities between this subclass of histidine phosphatases.
Docking to 55-HPD—Because no information was available
on suitable in vivo substrates of 55-HPD, we performed dock-
ing studies using the crystal structure of 55-HPD. The first,
TABLE 2
Crystallographic statistics for Huf
Huf (Native)
Data collection
Space group P3221
Cell dimensions
a b, c (Å) 86.7, 99.0
Wavelength (Å) 0.97633
Resolution (Å) 50.0-2.05 (2.10-2.05)
Rsym (%) 7.0 (99.2)
I/(I) 18.2 (2.54)
Completeness (%) 99.9 (99.9)
Multiplicity 11.2 (11.4)
Refinement
Resolution (Å) 40.0-2.05
No. reflections 27,399
Rwork/Rfree (%) 20.0/23.6
No. atoms
Protein 2,040
Other 3
Water 110
B-factor (Å2)
Protein 56.9
Other 43.9
Water 52.4
RMSD
Bond lengths (Å) 0.007
Bond angles (°) 0.913
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unbiased round of docking used 15,402 molecules of the Kyoto
Encyclopedia of Genes and Genomes database (11, 12). The
top-ranked 500 molecules were inspected visually for the feasi-
bility of their binding pose, namely, satisfied hydrogen bond
interactions, lack of strain in the molecules, and correctness of
the protonation state. The vast majority of the highest ranking
500 molecules (even those that did not pass the visual inspec-
tion) contained a phosphate group (Fig. 3C). Among the 31
molecules with reasonable binding modes, mainly phosphory-
lated sugars and nucleotides were found, likely a tribute to the
polar nature of the binding site.We tested two of these hits that
were commercially available, namely AMP and Ser(P), as
potential substrates for 55-HPD and Huf in in vitro phospha-
tase assays. Although we detected some residual activity, the
enzymatic activities are much lower than those of known
highly active phosphatases for these small compounds, like
alkaline phosphatase (calf intestinal) and  phage protein phos-
phatase (Fig. 3D).
FIGURE 2. Identification of the phosphatase activity of 55-HPD and Huf. A, structure of the 55-HPD active site in cartoon representation. Active site
residues and the phosphate ion are shown in ball and stick representation. The residues are numbered and colored in green. Refined 2mFoDFc density of the
ligand is shownasmesh.B, sameas inA for theHuf active sitewith thebound formate ion.C, representative SDS-PAGEofpurifiedwild typeandmutantproteins
used for the subsequent assays. FL, full length.D, thermostability analyses of purified proteins usingdifferential scanning fluorometry. E, absolute fluorescence
values obtained from the OMFP phosphatase assays using 55, 55-HPD Huf, Sts-1, and the respective mutant proteins. F, calculated kinetic parameters for
55-HPD, Huf, Sts-1, and Sts-2. The values for Sts-2 are taken from Ref. 22.
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Because 55-HPD and Huf showed the highest similarity to
Sts-1 and Sts-2, two known protein phosphatases, calculations
were extended to phosphorylated di- and tripeptides with the
aim to explain the preferences of 55-HPD toward certain pep-
tide sequences. Of the five tripeptides corresponding to the
three central amino acids of the tested Pol II peptides (below),
only two, the SpYS and YpSP peptides, docked with highly
favorable scores and with the phosphate positioned between
Arg-10, Arg-14, Arg-68, and His-169. However, the rather nar-
row nature of the binding site seemed to be more compatible
with the dephosphorylation of a tyrosine residue, because it
allows a more relaxed geometry of the peptide backbone.
In Vitro Analysis of the Substrate Specificity of 55-HPD and
Huf—55 is an integral part of the general transcription factor
TFIIIC, which in addition to Pol III-dependent transcription,
has been recently shown to be involved in Pol III-independent
cellular processes (25, 26). In detail, TFIIIC was found to local-
ize to genomic extra TFIIIC sites, which are often in close prox-
imity of Pol II genes (27) and to regulate the expression of one of
its own subunits from a Pol II specific promoter (26). Further-
more, Pol III-transcribed genes are often co-occupied by Pol II
and are situated in regions with epigenetic marks resembling
functional Pol II promoters (28, 29). Therefore, we tested the
phosphatase activity of 55-HPD, Huf with Sts-1 as control
toward a series of candidate peptides known to be phosphoryl-
ated in the Pol III transcription system and a set of known
monophosphorylated Pol II C-terminal domain (CTD) pep-
tides (Fig. 4, A and B) (30–33). Strikingly, we observed specific
phosphatase activity for all three enzymes toward the
Tyr(P)-Y1 peptide, which recently has been shown to be impor-
tant for regulating the recruitment of transcription termination
factors within the Pol II transcription cycle (34). In contrast,
Ser(P)-2, Thr(P)-T4, Ser(P)-5, and Ser(P)-7 peptides are not
hydrolyzed by 55-HPDorHuf. Not only 55-HPDby itself, but
also full-length 55 and the 55/95 heterodimer are also able to
specifically dephosphorylate Tyr(P)-1 (Fig. 4, C and D).
Although with lower activity, Huf is also able to specifically
dephosphorylate a phosphoserine peptide derived from C53, a
FIGURE 3. Docking studies of 55-HPD. A, docked poses of AMP, Ser(P), and OMFP in the binding site of 55-HPD. 55-HPD is colored gray and shown in
cartoon representation. Active site residues from Fig. 2 are labeled and shown in ball and stick representation. AMP (light blue), phosphoserine (dark blue),
OMFP (yellow), and the phosphate ion in the crystal (green) are shown as lines. B, docked poses of two dipeptides, namely SpY and pYS as present in the Pol II
CTD.C, overviewof the usednumbers ofmolecules duringdifferent steps of the dockingprocedure.D, dephosphorylation activities of 55-HPD, Huf, Sts-1, calf
intestinal alkaline phosphatase (CIP), and  phage protein phosphatase (Lambda). Activities were measured by PiColorLock Gold Assay kit and are shown for
each substrate in relative activities compared with 55-HPD.
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specific subunit of Pol III (Fig. 4B, inset) known to be contacted
by TFIIIC (35). Neither 55-HPD nor Sts-1 showed any detect-
able phosphatase activity toward the Pol III-related phospho-
peptides tested. To relate the phosphatase activity of 55-HPD,
Huf, and Sts-1 with other well characterized phosphatases, we
also compared their relative activities with the activities of 
protein phosphatase and calf intestinal phosphatase.  protein
phosphatase and calf intestinal phosphatase hydrolyze a phos-
photyrosine containing peptide (but also AMP and phospho-
serine) with 50- to 500-fold higher activity, whereas 55-
HPD, Huf, and Sts-1 show very comparable activities (Fig. 3D).
We therefore conclude that 55-HPD and Huf show similar
activities and preferences toward phosphotyrosine containing
peptides like the well characterized Sts-1/2 proteins (20, 21).
For Huf, we could also demonstrate that it dephosphorylates
phosphoserine-containing peptides, whereas for 55-HPD, no
phosphoserine-containing peptide was identified as a possible
substrate.
In Vivo Identification of Potential 55-HPD and Huf-regu-
lated Phosphosites—Although 55-HPD andHuf are conserved
in the Saccharomyces clade and 55-HPD is conserved in all
hemiascomycetes, there are no obvious phenotypes connected
to the deletion of the two described phosphatase domains
under normal growth conditions in S. cerevisiae (10, 36). Con-
sidering the above described highly specific in vitro peptide
phosphatase activities, we investigated the effects of deleting
these two potentially redundant phosphatase domains on the
yeast phosphoproteome. Because the C terminus of 55 is
essential, we generated a knock-out strain that specifically lacks
the 55-HPDby rescuing a full-length 55 deletion strain with a
plasmid expressing only the C-terminal part of 55 (hereafter
called 55-HPD). We further knocked out Huf in the 55-
HPD strain to obtain a strain lacking both phosphatase
domains (hereafter called 55-HPD huf). In addition, we
rescued the 55 deletion strain with a plasmid expressing full-
length 55, which served as the wild type control strain. We
used this control wild type strain to guarantee the comparison
of strains with the most similar genetic background possible.
Consistent with the literature, we could not observe any obvi-
ous growth phenotypes between 55-HPD huf and the used
wild type strain (10, 36). In a subsequent step we compared the
phosphoproteomes of both strains by mass spectrometry using
differential isotopic dimethyl labeling. In a second round, we
also analyzed the heparin-bound fraction of the yeast phospho-
proteome enriched in DNA-binding proteins (Fig. 5A). By
focusing on the DNA-binding proteome, we attempted to facil-
itate the identification and analyses of regulated phosphosites
present in transcriptional complexes. Each of these experi-
ments was performed in duplicate combinedwith swapping the
labels on the individual replicates.
In the combined data set, we identified 1706 protein groups
in both replicates (2261 and 1787, respectively), of which we
could quantify 1281 containing at least three unique peptides.
None of the proteins showed a more than 2-fold increase of
their relative abundance in the 55-HPD huf strain of both
replicates compared with the wild type strain. Only for seven
proteins and one protein group containing two proteins, we
observed a more than 2-fold decrease of relative abundance in
the 55-HPD huf strain compared with the wild type (Fig. 5,
B andC, and supplemental Table S1).We subsequently focused
on the identification of phosphopeptides following an opti-
mized TiO2 phosphopeptide enrichment step. Of the pool of
over 1900 identified phosphopeptides, 200 phosphopeptides
were more than 2-fold up- or down-regulated in at least one of
the two replicates. To focus on phosphopeptides with the high-
est reliability, we only kept the ones identified in both repli-
cates. In the 55-HPD huf strain, 14 of those were down-
regulated (less phosphorylated) in both replicates by at least
2-fold, suggesting indirect effects (see discussion). Our special
interest was raised by the protein UTP-glucose-1-phosphate
FIGURE 4. Investigation of the substrate specificities of 55-HPD and Huf. A, description of all phosphopeptides used in the assays. B, dephosphorylation
activities of 55-HPD, Huf, Sts-1, and the respective active site mutants using Pol II CTD and Pol III-related phosphopeptides. C, schematic model of the TFIIIC
complex, highlighting subunits 55 and 95. D, dephosphorylation activities of 95/55, 55, 55-HPD, and Huf using CTD phosphopeptides.
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uridylyltransferase (Ugp1) that contains the only phosphopep-
tide that was strongly up-regulated (more phosphorylated) in
the 55-HPD huf strain in both replicates. Of all regulated
phosphopeptides, this is the only peptide where the phosphor-
ylation state was found more than 5-fold changed in both
replicates, suggesting that Ugp1 is a direct target of 55-HPD
and/or Huf as discussed below (Fig. 5D and supplemental
Table S2).
DISCUSSION
Our in vitro results identify 55 and Huf as bona fide phos-
phatases. Using the high resolution crystal structure of 55-
HPD, we docked a large number of small molecules and a vari-
ety of di- and tripeptides into the crystal structure. Possible
substrates included phosphorylated sugars and nucleotides, as
well as different phosphopeptides, some of which were subse-
quently experimentally tested in vitro. Remarkably, the in silico
FIGURE 5. Identification of in vivo target sites of 55-HPD and Huf. A, experimental workflow used for the comparative phosphoproteomics approach.
B, combined histogram and scatter blot analysis of protein quantification in label swop experiments. C, list of proteins that show decreased abundance in the
55-HPDhuf strain.D, list of proteins containing phosphopeptides that show changed abundance in the 55-HPDhuf strain andGOannotation of these
proteins.
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results were well in line with subsequent experimental mea-
surements, which demonstrates the strong preorganization of
the binding pocket for recognizing phosphatemoieties, asman-
ifested by the vastly enriched phosphate-bearing molecules in
the top hits. Protein phosphorylation events play important
roles in regulating all known cellular functions, including the
general transcription machinery. It therefore appears plausible
to speculate that the general transcription factor IIIC uses its
“built-in” 55-HPD protein phosphatase activity to regulate its
transcription machinery, thereby contributing to the orches-
trated balance between phosphorylation and dephosphory-
lation events. In addition, the heterodimeric 95/55 subcom-
plex that exists independently of TFIIIC and the paralogue Huf
could dephosphorylate additional components of the tran-
scriptionmachinery in vitro, thereby complementing the activ-
ity of the TFIIIC-bound 55 protein. Consistent with an
involvement of 55 and Huf in transcription regulation, both
proteins are localizing to the nucleus (37). Despite the plausi-
bility of our hypothesis, using a broad in vivo phosphopro-
teomic approach, we were not able to reliably detect any of the
phosphopeptides used in our in vitro dephosphorylation assay
that are present in components of the transcriptionmachinery.
Further studies will have to clarify whether these peptides are
not detected for technical reasons (e.g., proteome coverage,
sampling rate, strict filtering criteria), if they are not phosphor-
ylated under the tested environmental conditions, whereas
they are genuine in vivo targets under different growth condi-
tions, orwhether they are simply not targets of 55-HPDand/or
Huf. We also observed lower phosphorylation states for 14
phosphopeptides in the 55-HPD huf strain lacking the two
phosphatases. This result appears counterintuitive but suggests
that these peptides are downstream targets of 55-HPD and/or
Huf and are indirectly influenced by them. Strong indirect
responses have been also observed in earlier system-wide stud-
ies of protein kinases and phosphatases in yeast (38). Finally, the
in vivo tyrosine phosphatase activity of 55-HPD and Huf also
needs to be analyzed in greater detail. The abundance of phos-
photyrosine containing peptides is known to be very low in
yeast, and it is difficult to investigate their status in a global
phosphoproteome analysis. A more specific proteomic approach
especially targeting phosphotyrosine peptides will have to be
applied in future studies to clarify the contribution of 55-HPD
and Huf in the in vivo dephosphorylation of phosphotyrosine
sites. In this study, we identified several targets with most of
them showing no direct connection to transcription regulation,
but we have identified effects of 55-HPD and Huf on a set of
proteins involved in metabolism. Interestingly, we observed
lower abundance of several mitochondrial proteins in the 55-
HPD huf strain that are mainly associated with metabolic
functions. This finding might explain the earlier described
observation that 55-HPD andHuf have an effect onmitochon-
drial protein synthesis (39). Another strong effect includes the
regulation of the major metabolic enzyme Ugp1.We show that
the phosphorylation of an N-terminal peptide of Ugp1 is
strongly up-regulated after the depletion of 55-HPD and Huf,
which suggests that Ugp1 is a direct and specific target of these
phosphatases. It was shown earlier that the phosphorylation of
serine 11 of Ugp1 is important for changing the metabolic net-
works from glycogen synthesis toward intensive glucan pro-
duction, whereas the inability to phosphorylate Ugp1 leads to a
weak cell wall and increased glycogen content in the cell (40).
These observations strongly support our results that Ugp1 is a
direct target of 55-HPD and Huf. It is also interesting to note
that a partial 55-HPD deletion leads to increased sensitivity of
yeast cells to low concentrations of calcofluor white and caf-
feine, which are two cell wall-interfering drugs (41).
In conclusion, at present our in vivo results demonstrate that
55-HPD as an integral part of the general transcription factor
TFIIIC and its paralogueHufmainly affectmetabolic processes.
Further analysis might identify additional proteins that are
directly or indirectly affected by both phosphatases and will
further clarify the link between the transcriptional regulator
TFIIIC and metabolic signaling networks.
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